Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 6Phase 1/2 4Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Glioblastoma 7Glioma 6Brain Neoplasms 3Neuroblastoma 2Sarcoma 1Rhabdoid Tumor 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Medulloblastoma 1Gliosarcoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Desmoplastic Small Round Cell Tumor 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 3Oncolytic Virotherapy 3Magnetic Resonance Spectroscopy 3Specimen Handling 2Radiotherapy 2Nivolumab 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2trastuzumab biosimilar HLX02 1sodium thiosulfate 1pertuzumab 1perflutren 1palbociclib 1olaparib 1niraparib 1montelukast 1eribulin 1entrectinib 1cobimetinib 1camrelizumab 1atezolizumab 1apatinib 1alovudine 1alectinib 1X-Rays 1Vinorelbine 1Vincristine 1Vemurafenib 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sarcoma × Temozolomide × Clear all
NCT01189643 2025-09-05

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Active not recruiting
15 enrolled
Sarcoma

Sarcoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡